内镜下治疗声门下狭窄
该研究纳入1995至2015年在一家四级学术医疗中心接受内镜治疗的101例成人声门下狭窄患者,分析手术方式及辅助措施与再次手术间隔的关系。结果显示,丝裂霉素应用与下次手术间隔从317天延长至474天相关(绝对差值157天;95%CI 15-299天),而激光或球囊扩张技术、狭窄分级及激素注射未显著改变手术间隔。
要点
- 丝裂霉素应用与内镜治疗间隔延长相关:从317天增至474天(绝对差值157天;95%CI 15-299天)。
- 激光径向切开、球囊扩张等手术技术未显著改变手术间隔。
- 狭窄高级别和激素注射未显著改变手术间隔。
核心结论
- 内镜手术是声门下狭窄患者管理的关键环节;手术技术和狭窄分级未见改变手术间隔;丝裂霉素应用与内镜治疗间隔延长相关。
研究设计与样本
- 研究为在四级学术医疗中心开展的成人声门下狭窄内镜治疗分析,纳入1995至2015年治疗的患者。
- 共纳入101例孤立性声门下(环气管)狭窄且年龄18岁及以上的患者,排除既往开放手术、喉部手术、声门狭窄或声带麻痹者。
- 患者接受激光径向切开、球囊扩张或两者联合,部分患者接受局部丝裂霉素、糖皮质激素注射或两者联合。
主要发现
- 患者平均(SD)年龄52.3(15.9)岁,女性占77.2%;病因包括特发性47例(46.5%)、插管31例(30.7%)、肉芽肿性多血管炎9例(8.9%)和其他自身免疫病6例(5.9%)。
- 219次手术中,激光联合球囊扩张117次(53.4%),单纯球囊扩张96次(43.8%),单纯激光6次(2.7%);丝裂霉素应用144次(65.8%),激素注射93次(42.5%)。
- 丝裂霉素应用与下次手术平均间隔从317天延长至474天相关(绝对差值157天;95%CI 15-299天)。
- 狭窄高级别、扩张技术和激素注射未显著改变手术间隔。
关键数值与推荐
- 丝裂霉素应用者下次手术平均间隔为474天,未应用者为317天,绝对差值157天(95%CI 15-299天)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Optimal management of subglottic stenosis has not been established. Endoscopic techniques include balloon dilation, radial incisions with carbon dioxide laser or cold knife, and combinations of techniques. Adjunctive measures include mitomycin application and glucocorticoid injection. OBJECTIVE: To determine whether surgical technique or adjunctive measures are associated with duration between surgical procedures. DESIGN, SETTING, AND PARTICIPANTS: Adult patients with subglottic stenosis treated endoscopically between 1995-2015 at a quaternary academic medical center were identified. Patients with isolated subglottic (cricotracheal) stenosis 18 years and older were included. Patients with prior open surgical procedures, prior laryngeal surgical procedures, glottic stenosis, or vocal fold paralysis were excluded. INTERVENTIONS: Patients underwent endoscopic procedures including laser radial incisions, balloon dilation, or both, with some patients receiving topical mitomycin, glucocorticoid injection, or both. MAIN OUTCOMES AND MEASURES: Time interval between endoscopic treatments. RESULTS: A total of 101 patients (mean [SD] age, 52.3 [15.9] years; 77.2% female) were included in the analysis, with etiologies including idiopathic (47 [46.5%]), intubation (31 [30.7%]), granulomatosis with polyangiitis (9 [8.9%]), and other autoimmune diseases (6 [5.9%]). Among the 219 operations, both laser and balloon dilation were used in 117 (53.4%), while balloon dilation alone was used in 96 (43.8%) and laser alone in 6 (2.7%). Mitomycin application and steroid injection were used in 144 (65.8%) and 93 (42.5%) cases, respectively. Mitomycin application was associated with improvement in the mean interval to next procedure from 317 to 474 days (absolute difference, 157 days; 95% CI, 15-299 days). Advanced grade of stenosis, dilation technique, and steroid injection did not significantly alter the surgical intervals. CONCLUSIONS AND RELEVANCE: Endoscopic surgery for subglottic stenosis is a critical aspect of patient management. Neither surgical technique nor grade of stenosis was seen to alter the surgical intervals. Mitomycin application was associated with an extended time interval between endoscopic treatments.
引用
- Feinstein AJ, Goel A, Raghavan G, et al. Endoscopic Management of Subglottic Stenosis. JAMA Otolaryngol Head Neck Surg. 2017. PMID: 28241174. doi:10.1001/jamaoto.2016.4131
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。